Cytotoxic Pt(II) complexes containing alizarin: a selective carrier for DNA metalation

Rossella Caligiuri1, Lara Massai2, Andrea Geri2

  • 1MAT-INLAB, LASCAMM CR-INSTM, Unità INSTM della Calabria, Dipartimento di Chimica e Tecnologie Chimiche, Università della Calabria, Ponte Pietro Bucci Cubo 14C, Arcavacata di Rende (CS), 87036, Italy. iolinda.aiello@unical.it.

Insights

Researchers developed new platinum(II) complexes with alizarin ligands to target triple-negative breast cancer. Complex 6b showed promising anticancer activity and selective targeting, warranting further investigation as a potential therapeutic agent.

Area of Science:

  • Inorganic Chemistry
  • Medicinal Chemistry
  • Cancer Biology

Background:

  • Selective drug delivery enhances anticancer agent efficacy, particularly for challenging cancers like triple-negative breast cancer.
  • Platinum(II) complexes are investigated for cancer treatment, but resistance mechanisms can limit their effectiveness.
  • Alizarin is explored as a protective ligand to improve the stability and targeting of platinum(II) pharmacophores.

Purpose of the Study:

  • To synthesize and characterize novel neutral mixed-ligand platinum(II) complexes incorporating alizarin.
  • To evaluate the in vitro cytotoxicity of these complexes against triple-negative breast cancer cell lines.
  • To investigate the potential of alizarin as a selective carrier for platinum(II) anticancer agents.

Main Methods:

  • Synthesis of platinum(II) complexes with alizarin and diamine ligands.
  • Spectroscopic characterization using FT-IR, NMR, and UV-Vis analyses.
  • In vitro cytotoxicity assays against triple-negative breast cancer cell lines.
  • Electrospray ionization mass spectrometry (ESI-MS) studies to assess interactions with model proteins and DNA fragments.

Main Results:

  • Three platinum(II) compounds (2b, 6b, 7b) exhibited varying cytotoxic effects.
  • Complex 6b demonstrated significant cytotoxicity (10.49 ± 1.21 μM) against triple-negative breast cancer cells.
  • ESI-MS studies provided insights into the interaction mechanisms of the complexes with biological targets.

Conclusions:

  • Alizarin can function as a selective carrier for platinum(II) anticancer agents.
  • Complex 6b shows potential as a prospective anticancer agent for triple-negative breast cancer.
  • Further investigations into complex 6b are warranted for its therapeutic development.

Related Concept Videos

Phase II Reactions: Miscellaneous Conjugation Reactions01:19

Phase II Reactions: Miscellaneous Conjugation Reactions

Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
62
Aryldiazonium Salts to Azo Dyes: Diazo Coupling01:11

Aryldiazonium Salts to Azo Dyes: Diazo Coupling

The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
2.9K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
13.4K
EDTA: Auxiliary Complexing Reagents01:26

EDTA: Auxiliary Complexing Reagents

EDTA titrations are usually carried out in highly basic conditions, where the fully deprotonated form of EDTA, Y4−, actively complexes with the free metal ions in the solution. Several metal ions precipitate as hydrous oxide (hydroxides, oxides, or oxyhydroxides) under these conditions, lowering the concentration of free metal ions in the solution. For this reason, auxiliary complexing agents or ligands such as ammonia, tartrate, citrate, or triethanolamine are used in EDTA titrations to...
589
Extraction: Advanced Methods00:56

Extraction: Advanced Methods

Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
447